Effects of repeated dizocilpine treatment on adult rat behavior after neonatal lesions of the entorhinal cortex

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 3, 2008, Pages 816-827

  Harich, Silke ^a   Koch, Michael ^a   Schwabe, Kerstin ^a  

^a UNIVERSITY OF BREMEN   (Germany)

Author keywords

Behavioral flexibility; Locomotor activity; Neurodevelopment; NMDA receptor antagonist; Sensorimotor gating

Indexed keywords

DIZOCILPINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SCIENCE; BRAIN DAMAGE; CONTROLLED STUDY; DRUG EFFECT; ENTORHINAL CORTEX; MALE; MAZE TEST; NONHUMAN; PREPULSE INHIBITION; RAT; SENSORIMOTOR FUNCTION;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN INJURIES; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DRUG ADMINISTRATION SCHEDULE; ENTORHINAL CORTEX; EXPLORATORY BEHAVIOR; IBOTENIC ACID; INHIBITION (PSYCHOLOGY); MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 39749123307     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.12.015     Document Type: Article

References (78)

1. Akil M., and Lewis D.A. Cytoarchitecture of the entorhinal cortex in schizophrenia. Am J Psychiatry 154 (1997) 1010-1012
2. Al Amin H.A., Weinberger D.R., and Lipska B.K. Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus. Behav Pharmacol 11 (2000) 269-278
3. Al Amin H.A., Shannon W.C., Weinberger D.R., and Lipska B.K. Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus. Biol Psychiatry 49 (2001) 528-539
4. Arnold S.E., Hyman B.T., Van Hoesen G.W., and Damasio A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 48 (1991) 625-632
5. Bachus S.E., Hyde T.M., Herman M.M., Egan M.F., and Kleinman E.J. Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics. J Psychiatr Res 31 (1997) 233-256
6. Becker A., Grecksch G., Bernstein H.G., Hollt V., and Bogerts B. Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology 144 (1999) 333-338
7. Beckmann H. Developmental malformations in cerebral structures of schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 249 (1999) 44-47
8. Birrell J.M., and Brown V.J. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20 (2000) 4320-4324
9. Breese G.R., Knapp D.J., and Moy S.S. Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness. Neurosci Biobehav Rev 26 (2002) 441-455
10. Castellani S., and Adams P.M. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur J Pharmacol 73 (1981) 143-154
11. Chambers R.A., Moore J., McEvoy J.P., and Levin E.D. Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 15 (1996) 587-594
12. Chang Q., and Gold P.E. Switching memory systems during learning: changes in patterns of brain acetylcholine release in the hippocampus and striatum in rats. J Neurosci 23 (2003) 3001-3005
13. Dalley J.W., Cardinal R.N., and Robbins T.W. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28 (2004) 771-784
14. Dolorfo C.L., and Amaral D.G. Entorhinal cortex of the rat: organization of intrinsic connections. J Comp Neurol 398 (1998) 49-82
15. Duncan G.E., Moy S.S., Knapp D.J., Mueller R.A., and Breese G.R. Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res 787 (1998) 181-190
16. Duncan G.E., Sheitman B.B., and Lieberman J.A. An integrated view of pathophysiological models of schizophrenia. Brain Res Rev 29 (1999) 250-264
17. Eastwood S.L., Burnet P.W.J., and Harrison P.J. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 66 (1995) 309-319
18. Eijkenboom M., Blokland A., and van der Staay F.J. Modelling cognitive dysfunctions with bilateral injections of ibotenic acid into the rat entorhinal cortex. Neuroscience 101 (2000) 27-39
19. Falkai P., Bogerts B., and Rozumek M. Limbic pathology in schizophrenia: the entorhinal region - a morphometric study. Biol Psychiatry 24 (1988) 515-521
20. Falkai P., Schneider-Axmann T., and Honer W.G. Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol Psychiatry 47 (2000) 937-943
21. Floresco S.B., and Magyar O. Mesocortical dopamine modulation of executive functions: beyond working memory. Psychopharmacology 188 (2006) 567-585
22. Geyer M.A., Krebs-Thomson K., Braff D.L., and Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156 (2001) 117-154
23. Goff D.C., and Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158 (2001) 1367-1377
24. Goto K., Ueki A., Iso H., and Morita Y. Reduced prepulse inhibition in rats with entorhinal cortex lesions. Behav Brain Res 134 (2002) 201-207
25. Goto K., Ueki A., Iso H., and Morita Y. Involvement of the nucleus accumbens dopaminergic transmission in acoustic startle: observations concerning prepulse inhibition in rats with entorhinal cortex lesions. Psychiatry Clin Neurosci 58 (2004) 441-445
26. Grecksch G., Bernstein H.G., Becker A., Hollt V., and Bogerts B. Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology 20 (1999) 525-532
27. Harich S., Koch M., Schwabe K. (2006). Neonatal lesions of the entorhinal cortex lead to structural deficits of limbic brain regions together with disturbed maze learning in adult rats (under revision).
28. Hemby S.E., Ginsberg S.D., Brunk B., Arnold S.E., Trojanowski J.Q., and Eberwine J.H. Gene expression profile for schizophrenia. Arch Gen Psychiatry 59 (2002) 631-640
29. 1 receptor agonists and antagonists. Psychopharmacology 187 (2006) 245-259
30. Hori T., Subramaniam S., Srivastava L.K., and Quirion R. Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions. Neuropharmacology 39 (2000) 2478-2491
31. Jakob H., and Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65 (1986) 303-326
32. Jakob H., and Beckmann H. Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspects. J Neural Transm 98 (1994) 83-106
33. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148 (1991) 1301-1308
34. Jentsch J.D., and Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20 (1999) 201-225
35. Jentsch J.D., and Taylor J.R. Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats. Neuropsychopharmacology 24 (2001) 66-74
36. Kato K., Shishido T., Ono M., Shishido K., Kobayashi M., Suzuki H., et al. Effects of phencyclidine on behavior and extracellular levels of dopamine and its metabolites in neonatal ventral hippocampal damaged rats. Psychopharmacology 150 (2000) 163-169
37. Keseberg U., and Schmidt W.J. Low-dose challenge by the NMDA receptor antagonist dizocilpine exacerbates the spatial learning deficit in entorhinal cortex-lesioned rats. Behav Brain Res 67 (1995) 255-261
38. Kesner R.P., Bolland B.L., and Dakis M. Memory for spatial locations, motor responses, and objects: triple dissociation among the hippocampus, caudate nucleus, and extrastriate visual cortex. Exp Brain Res 93 (1993) 462-470
39. Kesner R.P., Hunt M.E., Williams J.M., and Long J.M. Prefrontal cortex and working memory for spatial response, spatial location, and visual object information in the rat. Cereb Cortex 6 (1996) 311-318
40. Kovalenko S., Bergmann A., Schneider-Axmann T., Ovary I., Majtenyi K., Havas L., et al. Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesis. Pharmacopsychiatry 36 Suppl3 (2003) S158-S161
41. Krimer L.S., Herman M.M., Saunders R.C., Boyd J.C., Hyde T.M., Carter J.M., et al. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cereb Cortex 7 (1997) 732-739
42. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51 (1994) 199-214
43. Le Pen G., Grottick A.J., Higgins G.A., Martin J.R., Jenck F., and Moreau J.L. Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia. Behav Pharmacol 11 (2000) 257-268
44. Lipska B.K., and Weinberger D.R. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Dev Brain Res 75 (1993) 213-222
45. Lipska B.K., and Weinberger D.R. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology 10 (1994) 199-205
46. Lipska B.K., and Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23 (2000) 223-239
47. Lipska B.K., Jaskiw G.E., and Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9 (1993) 67-75
48. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., and Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 122 (1995) 35-43
49. Lipska B.K., al-Amin H.A., and Weinberger D.R. Excitotoxic lesions of the rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology 19 (1998) 451-464
50. Lipska B.K., Aultman J.M., Verma A., Weinberger D.R., and Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 27 (2002) 47-54
51. Lysaker P.H., Bell M.D., Bryson G., and Kaplan E. Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function. Acta Psychiatr Scand 97 (1998) 297-301
52. Mansbach R.S., and Geyer M.A. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2 (1989) 299-308
53. Martinez Z.A., Ellison G.D., Geyer M.A., and Swerdlow N.R. Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats. Neuropsychopharmacology 21 (1999) 28-39
54. Mizukami K., Ishikawa M., Hidaka S., Iwakiri M., Sasaki M., and Iritani S. Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brin. Prog Neuro-Psychopharmacol Biol Psychiatry 26 (2002) 393-396
55. Olney J.W., and Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52 (1995) 998-1007
56. Olney J.W., Newcomer J.W., and Farber N.B. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33 (1999) 523-533
57. Packard M.G. Glutamate infused posttraining into the hippocampus or caudate-putamen differentially strengthens place and response learning. Proc Natl Acad Sci U S A 96 (1999) 12881-12886
58. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, San Diego
59. Perry W., and Braff D.L. A multimethod approach to assessing perseverations in schizophrenia patients. Schizophr Res 33 (1998) 69-77
60. Pouzet B., Zhang W.N., Weiner I., Feldon J., and Yee B.K. Latent inhibition is spared by N-methyl-d-aspartate (NMDA)-induced ventral hippocampal lesions, but is attenuated following local activation of the ventral hippocampus by intracerebral NMDA infusion. Neuroscience 124 (2004) 183-194
61. Ragozzino M.E., and Kesner R.P. The role of rat dorsomedial prefrontal cortex in working memory for egocentric responses. Neurosci Lett 308 (2001) 145-148
62. Ragozzino M.E., Detrick S., and Kesner R.P. Involvement of the prelimbic-infralimbic areas of the rodent prefrontal cortex in behavioral flexibility for place and response learning. J Neurosci 19 (1999) 4585-4594
63. Ramirez J.J., Campbell D., Poulton W., Barton C., Swails J., Geghman K., et al. Bilateral entorhinal cortex lesions impair acquisition of delayed spatial alternation in rats. Neurobiol Learn Mem 87 (2007) 264-268
64. Risterucci C., Terramorsi D., Nieoullon A., and Amalric M. Excitotoxic lesions of the prelimbic-infralimbic areas of the rodent prefrontal cortex disrupt motor preparatory processes. Eur J Neurosci 17 (2003) 1498-1508
65. Robbins T.W. Homology in behavioural pharmacology: an approach to animal models of human cognition. Behav Pharmacol 9 (1998) 509-519
66. Schmadel S., Schwabe K., and Koch M. Effects of neonatal excitotoxic lesions of the entorhinal cortex on cognitive functions in the adult rat. Neuroscience 128 (2004) 365-374
67. Schulz B., Fendt M., Pedersen V., and Koch M. Sensitization of prepulse inhibition deficits by repeated administration of dizocilpine. Psychopharmacology 156 (2001) 177-181
68. Schwabe K., and Koch M. Role of the medial prefrontal cortex in N-methyl-d-aspartate receptor antagonist induced sensorimotor gating deficit in rats. Neurosci Lett 355 (2004) 5-8
69. Schwabe K., Enkel T., Klein S., Schuette M., and Koch M. Effects of neonatal lesions of the medial prefrontal cortex on adult rat behaviour. Behav Brain Res 153 (2004) 21-34
70. Schwabe K., Brosda J., Wegener N., and Koch M. Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats. Pharmacol Biochem Behav 80 (2005) 213-219
71. Schwabe K., Klein S., and Koch M. Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats. Behav Brain Res 168 (2006) 150-160
72. Totterdell S., and Meredith G.E. Topographical organization of projections from the entorhinal cortex to the striatum of the rat. Neuroscience 78 (1997) 715-729
73. Uehara T., Tanii Y., Sumiyoshi T., and Kurachi M. Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat. Brain Res 860 (2000) 77-86
74. Vollenweider F.X., Vontobel P., Oye I., Hell D., and Leenders K.L. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. J Psychiatr Res 34 (2000) 35-43
75. Weinberger D.R. Schizophrenia as a neurodevelopmental disorder. In: Hirsch S.R., and Weinberger D.R. (Eds). Schizophrenia (1995), Blackwell Science 293-323
76. Witter M.P., Groenewegen H.J., Lopes da Silva F.H., and Lohman A.H. Functional organization of the extrinsic and intrinsic circuitry of the parahippocampal region. Prog Neurobiol 33 (1989) 161-253
77. Wolf S.S., Hyde T.M., Saunders R.C., Herman M.M., Weinberger D.R., and Kleinman J.E. Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects. J Neural Transm 102 (1995) 55-65
78. Xu X., and Domino E.F. Phencyclidine-induced behavioral sensitization. Pharmacol Biochem Behav 47 (1994) 603-608